News US regulatory advisers to review Amgen's Humira biosimilar World's biggest selling drug could face competition.
Articles US physicians favour biosimilars As the US FDA moves towards issuing final guidelines on biosimilars, recent research with specialists in five main therapy areas suggests they are willing to embrace them if efficacy and safety
Articles UCB: growing sales and growing bones The specialist pharma company is set to expand into osteoporosis through its partnership with Amgen
News Myeloma drug Kyprolis launched in the UK Amgen has launched Kyprolis in the UK, joining a growing field of rival medicines for multiple myeloma.
News US pharma tariffs of up to 100% finalised by Trump Trump signs his pharma tariffs executive order, which won't affect most large pharma groups but could deal a hefty blow to smaller companies.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
